Physician profile
Jeffrey C Lee
NPI 1144283946
$2,688.20
in general payments reported to CMS, 2019-2025
6 companies · $769 in 2025
The $769 reported for 2025 was more than what 83% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2021: $145 · 2022: $195 · 2023: $68.47 · 2024: $666 · 2025: $769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $754 · Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $753.94 |
| Food and Beverage | $749.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $1,425.41 | 2019-2025 | Somatom Pro.Pulse, Naeotom Alpha, Magnetom Sola |
| Hitachi Healthcare Americas Corp. | $606.26 | 2019 | |
| Abbott Laboratories | $357.52 | 2024 | Jot Dx |
| Boston Scientific Corporation | $171.10 | 2022-2024 | Ams 700, Ams 800 Artificial Urinary Sphincter |
| Abbvie INC. | $112.23 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.